2 recruiting, 1 active not recruiting, 1 unknown. 3 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Acute Myeloid Leukemias: new trials by email Literature Review of Acute Myeloid Leukemias trials Research Report on Acute Myeloid Leukemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation Revumenib, Placebo, Intensive Chemotherapy Regimen - Acute Myeloid Leukemias | Phase 3 | Recruiting | Syndax Pharmaceuticals | 468 | 2025-11-25 | 2026-10-21 |
| A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) STX-0712 - Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML) | Phase 1 | Recruiting | Solu Therapeutics, Inc | 105 | 2025-03-13 | 2026-02-09 |
| A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias Revumenib, Chemotherapy Regimen, HiDAC - Acute Myeloid Leukemias | Phase 1 | Active not recruiting | Syndax Pharmaceuticals | 96 | 2024-05-21 | 2026-09-16 |
| Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells Haploidentical transplantation with donor NK cells - Acute Myeloid Leukemias, Advanced Hematological Malignancies | Phase 1 / Phase 2 | Unknown | Charite University, Berlin, Germany | 30 | 2001-07-01 | 2010-10-14 |
Leukemia, Myeloid, Acute (4) · Leukemia, Monocytic, Acute (1) · Leukemia, Myelomonocytic, Chronic (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia (4) · Leukemia, Myeloid (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Myelodysplastic-Myeloproliferative Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
revumenib (2) · Drug Therapy (1) · Transplantation, Haploidentical (1)
Syndax Pharmaceuticals (2) · Charite University, Berlin, Germany (1) · Solu Therapeutics, Inc (1)
United States (3) · Australia (2) · Canada (2) · Germany (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Austria (1) · Belgium (1) · Brazil (1) · France (1) · Georgia (1) · Greece (1) · Hungary (1) · Israel (1)
Dietger Niederwieser, MD (1) · Lutz Uharel, MD (1)
2025 (1)